mcn-jr-6218;8-(4,4-bis(4-fluorophenyl)butyl)-1-phenyl-1,3,8-triazaspiro(4.5)decan-4-one;FLUSPIRILENE (R6218) DOPAMINE ANTAGONIST;R 6218, 8-[4,4-bis(p-Fluorophenyl)butyl]-1-phenyl-1,3,8-triazino[4.5]decan-4-one;Fluspirilene,8-[4,4-bis(p-Fluorophenyl)butyl]-1-phenyl-1,3,8-triazino[4.5]decan-4-one, R 6218;Fluspirilen;Redeptin;Paroxetine EP IMpurity C
Fluspirilene is a long-acting injectable antipsychotic drug used for the treatment of schizophrenia; it acts as a non-competitive antagonist of L-type calcium channels (IC50 = 0.03 μM); it demonstrates anti-tumor activity by inhibiting the proliferation of glioma stem cell lines (including T98, U87, U251, SNB19, and GSC lines) in a dose-dependent manner; it reduces tumor size and significantly prolongs survival in the TGS04 mouse model.